L-Ascorbic Acid Shapes Bovine Pasteurella multocida Serogroup A Infection

Introduction

Pasteurella multocida (Pm) is a pathogenic Gram-negative bacterium with multiple host types, like chicken, pig, rabbit, and cattle. Clinically, Pm infection was mainly characterized by fowl cholera, swine atrophic rhinitis, rabbit septicemia, bovine pneumonia, etc. (1). Sometimes, humans can even be infected with Pm via animal bites and scratches (2). According to the capsular characteristics, Pm can be classed into A, B, D, E, and F serogroups (3). Among them, bovine P. multocida serogroup A (bovine PmA) is one of the most important pathogenic bacteria causing bovine pneumonia, with high morbidity and mortality around the world, which has led to immense economic losses in animal husbandry (4–6).

Generally, the most severely injured tissue is often accompanied by higher bacterial density (7–9). Cattle infected with bovine PmA usually exhibits serious pneumonia in clinic, and it was found that profuse growth of bovine PmA existed in the bovine lungs (10). A potential cause to this situation appears to be that the bactericidal activity of alveolar macrophage is weaker than peritoneal macrophage when exposed to PmA (11). Colonization is the prerequisite for infection, and various conditions can affect bacterial colonization, like host immunity, nutrition, bacterial virulence factors, and so on. For example, bacterial adhesin, an important bacteria virulence factor, is one prerequisite for bacterial colonization, which owns a precise selectivity for target molecules and recognizes molecular motifs in a lock and key mode (12). Another is that enterotoxigenic Escherichia coli (ETEC) strains need K88 fimbrial adhesin to adhere to the front of the piglet small intestine and then release enterotoxins to cause piglet diarrhea (13, 14). Recently, increasing researches demonstrated that nutrition plays a key role in bacterial infection. Haber and his co-workers reported that Listeria monocytogenes loads in tissues as well as the expression of virulence genes are dependent on L-glutamine levels (15). Likewise, Campylobacter jejuni loads are influenced by microbiota-derived short-chain fatty acid (16).

In our former works, we have found that some nutrition, particularly amino acids, played important roles in bovine PmA infection based on the mouse model (17–20). Considering that pneumonia is the most typical symptom of bovine PmA infection, the present work has found that the infected lungs had the highest bacterial density when compared with other organs. Then, metabolomics was employed to compare the metabolite profile difference between the high- and low-bacterial density tissues. Finally, this study has demonstrated that L-ascorbic acid (AA) shaped bovine PmA infection and AA could serve as a protective agent for anti-bovine PmA infection.

Materials and Methods

Bacterial Strains and Cultivation Condition

The bovine P. multocida serogroup A strains CQ2 (GenBank accession number: No. CP033599) and CQ6 (GenBank accession number: CP033600) were isolated in Chongqing and cultured on Martin's broth agar with 5% horse serum at 37°C (21). Escherichia coli DH5α was bought from a commercial company (Tiangen, Beijing, China) and stored in our laboratory. Bovine mastitis E. coli and Salmonella typhimurium were isolated from ill cattle in Chongqing. Mouse peritoneal macrophages were cultivated in Dulbecco's modified Eagle medium (DMEM) high glucose (hyclone) supplemented with 10% fetal bovine serum (GIBCO) at 37°C under 5% CO₂.

Animal Experiment

All animal experiments in this study have been granted permission by the Ethics Committee of Southwest University and likewise adopted the principles of Laboratory Animal Care of the National Institutes of Health, China (Permit No.11-1025). Female Kunming mice (6–8 weeks old, weighing 18–22 g) were purchased from the Institute of Chongqing Herb Medicine. Mice were kept in independently airy cages, lighting cycle at 12 h/day, keeping relative humidity at 50–60% as well as temperature at 20–30°C. For all infection experiments in this study, mice were infected with 10⁴ CFU log-phase growth PmCQ2 via intramuscular, intraperitoneal, or intranasal infection. Notably, 1.5% pentobarbital sodium was used to anesthetize mice before intranasal infection. After finishing infection experiment, mice were euthanized to collect their tissues.

Bacterial Colonization

Collected tissues were homogenized aseptically in 1 ml of saline and diluted to the appropriate gradient in saline to plate in triplicate on Martin's broth agar. Bacterial colonization was recorded via counting the average of CFU on this agar after 20-h cultivation at 37°C.

Histopathological Examination

For histopathological examination, tissues were promptly soaked in 4% paraformaldehyde for 36 h. These tissues then were dehydrated using gradient ethanol and embedded in paraffin. Afterwards, these paraffins were cut at 3 μm thick and stained with hematoxylin and eosin (H&E). H&E staining was estimated by three different researchers.

Sieving Metabolites

BacTrac™ 4300 Microbiological Analyzer (Sylab, Austria) was applied to analyze the influence of each metabolite on the bacterial growth. This apparatus can reflect the change of the bacterial growth via measuring impedance (22). Briefly, an approximate dose of 10⁴ CFU bacterial grown to log-phase was added rapidly into an aseptic test vial containing 8 ml of Martin's broth only or supplemented with a certain metabolite. Each group consisted of five individual test vials with the same treatment. Then, the vials were incubated at 37°C for more than 12 h, and a real-time impedance curve was given. The impact of one metabolite on bacterial growth can be reflected by the real-time impedance curve. The change of pH after adding a certain metabolite was adjusted by sodium hydroxide or hydrochloric acid.

Measurement of Bacterial Growth Curve

Bacterial growth curves were measured via the optical density value (OD₆₀₀) or the plate-counting method. In brief, an approximate dose of 10⁹ CFU bacteria grown to log-phase was rapidly added to an aseptic flask containing 100 ml of Martin's broth only or supplemented with a certain metabolite (n = 3 per group). The flasks were put into a shaker set to 37°C and speed at 220 rpm. Every 2 or 3 h, 1 ml of Martin's broth was taken aseptically and diluted to an appropriate dilution to estimate the optical density at 600 nm via using Vis Spectrophotometer (JINGHUA, China) or measure the bacteria number via the plate-counting method. Growth curves were drawn dependent on the results of different time points. The pH values were adjusted as above.

Q-PCR

Bacteria, cell, and tissue RNA were extracted using the total cell or tissue RNA extraction kit from Tiangen (China) and stored at −80°C, and RNA sample reverse transcription into cDNA used a FastKing reverse transcription kit from Tiangen (China). All operations were carried out according to the manufacturer's instruction. Q-PCR reaction was carried out with 1 μg of cDNA, 200 nM primer, and 5 μl of Bio-rad SYBR enzyme (USA) in a final volume of 10 μl by Bio-rad CFX96 machine. All primer sequences are available in Supplementary Table 1.

Isolation of Mouse Peritoneal Macrophage

Isolation of mouse peritoneal macrophage was manipulated as reported by Dey with some modifications (23). Briefly, mice received once intraperitoneal injections with 1.5 ml of 4% thioglycolate broth to stimulate macropahges biogenesis for 4 days. Afterwards, mice were euthanized and 4 ml of fresh DMEM high glucose medium was intraperitoneally injected to collect peritoneal lavage fluid. Centrifugation of the obtained peritoneal lavage solution at 1,800 rpm for 3 min and supernatant was removed. Finally, cells were resuspended with DMEM high glucose medium containing 10% fetal serum and these cells were ready to be used. Additionally, flow cytometer examination indicated that more than 90% cells isolated were positive for CD11b, a monocyte or macrophage marker, indicating that these cells belong to peritoneal macrophages.

Cell Viability Test

The cell viability test was performed by CCK-8 kit (Solarbio) according to the manufacturer's instruction. Briefly, suspension cells were added to a 96-well plate to ~2,000 cells per well, and cultivated for 2 h at 37°C under 5% CO₂ to allow cell adhesion, and washed three times with phosphate buffered saline (PBS, hyclone). Then, 10 μl of analyzed substance or saline was added to the experimental group, black group, and negative control group, respectively, and incubated for another 6 h. After that, the cells were washed three times with PBS, adding 10 μl of CCK-8 solution per well, and cells were incubated for another 4 h. Finally, the optical density at 450 nm was measured using a Microplate Reader (Thermo). Each group contains five repeats and the black group has no cell. The cell viability was estimated via the following formula:

$\begin{array}{l}\text{Cell viability }(\%)=(\text{experimental group}\\ -\text{black group})\text{/}(\text{negative control }-\text{ black group})\ast 100.\end{array}$

Phagocytosis and Intacellular Survival Assays

Phagocytosis assay was performed as described with some modifications (24). Mouse peritoneal macrophage of ~2 × 10⁵ cells were seeded per well in a 24-well plate. Bacteria grown to log-phase were harvested, washed, and resuspended in DMEM high glucose, and added to cells at a multiplicity of infection (MOI) of 1, as well as AA and Asp. After 2-h incubation, cells were rinsed three times with PBS and then added to DMEM high glucose containing 100 μg/ml ciprofloxacin solution for another 0.5 h to kill extracellular bacteria. Then, after rinsing three times with PBS, cells were lysed with 500 μl of PBS containing 0.1% Triton X-100 to release intracellular bacteria. The phagocytized bacteria were enumerated by the plate-counting method.

Intracellular survival analysis was carried out based on a previous report with some modifications (25). The procedures were the same as the phagocytosis assay except that AA, Asp, or saline was added to the medium after killing extracellular bacteria. The surviving bacteria were recorded by the plate-counting method. All assays have three independent experiments.

Biofilm Formation Assay

Biofilm assay was based on Anchanee's report with some modifications (26). Bacteria grown to log-phase in 100 μl of fresh Martin's broth supplemented with/without a substance were added to a 96-well plate to about 10⁷ CFU per well. The plate was incubated at 37°C for 48 h, and then it was washed three times with PBS. Next, each well was fixated with 100 μl of methanol for 15 min and methanol was removed. One hundred milliliters of 1% Crystal violet solution was added per well to dye cells for 5 min. After that, wells were washed with flowing water and dried at 37°C. Lastly, 100 μl of 33% glacial acetic acid solution was added to each well and their optical density was recorded using a Microplate Reader (Thermo) at OD₅₉₀.

AA Concentration Assay

Tissue AA concentration assay was operated using an AA assay kit (Sinobestbio, China) according to the manufacturer's instruction. In brief, tissues were mixed with solution buffer at 0.1 g/ml, homogenized on ice, and centrifugated for 20 min at 8,000 g under 4°C. Supernatant was collected and the optical density was measured using a Microplate Reader (Thermo) at OD₅₃₄. According to the standard curve, the tissue AA content can be figured out.

Statistical Analysis

GraphPad Prism software (Prism 6.0) and PASW Statistical 18.0 software (SPSS) were applied for statistical analyses. A group of individual data was expressed as means ± standard error of the mean (SEM), while the remainder of the data were expressed as means ± standard deviation (SD). Mice survival curves were assessed based on Kaplan–Meier analysis (Prism 6.0). Unpaired Student's t-test (Prism 6.0) was used to study the data between the two groups, while one-way ANOVA (SPSS) was applied to examine the data among more than two groups. The determinant of whether there is a significant difference is dependent on P < 0.05, and *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001, respectively.

Results

Bovine P. multocida Serogroup a Infection Causes Fatal Pneumonia in a Mouse Model

Clinically, the phenotype of bovine PmA infection is fatal pneumonia in cattle. Nevertheless, considering the price of using cattle as experimental model is too high and few SPF cattle are available today; our lab has successfully established a mouse model to mimic bovine PmA that caused pneumonia (20, 27). In this study, mice infected with bovine PmA (PmCQ2) always present some typical respiratory symptoms, such as cough and abdominal respiration. Likewise, H&E staining also shows serious lung damage and immune cell infiltration, such as lymphocyte and neutrophil, which indicates that bovine PmA has indeed caused a severe inflammatory reaction in the lung (Figures 1A,B). Additionally, mice infected with PmCQ2 exhibited high mortality rate, especially through intraperitoneal injection (Figure 1C). Together, these data suggested that mice infected with bovine PmA indeed induced fatal pneumonia.

FIGURE 1

Figure 1. PmCQ2 infection causes fatal pneumonia in mouse models and the infected lung has higher bacteria density than other tissue. (A,B) The lung pictures and H&E stainings (×400) of mice that were intranasally infected, intramuscularly infected, or intraperitionally infected with 10⁴ CFU log-phase PmCQ2 for 20 h, and the mice intranasally injected with saline (Control). The red circle indicates the lung damage and pulmonary effusion. (C) Survival rates of mice intranasally infected, intramuscularly infected, and intraperitionally infected with 10⁴ CFU log-phase PmCQ2. (D) A time-course assay reflecting the lung, liver, spleen, and kidney bacterial density of mice intranasally infected with 10⁴ CFU log-phase PmCQ2. Every single point represents one individual. (E) A time-course assay reflecting the lung, liver, spleen, and kidney bacterial density of mice intraperitoneal or intramuscular infected with 10⁴ CFU log-phase PmCQ2. Every single point represents one individual. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001, respectively.

The Lung Has the Highest Bacterial Density Compared to Other Organs Under Bovine PmA Infection

Next, considering the pneumonia phenotype caused by bovine PmA, we suggested that the lung might hold higher bacterial density than other tissues. As shown in Figures 1D,E, the infected lung has the highest bacterial density under intranasal infection, but the lung and the spleen equally contain the highest bacterial density under intraperitoneal infection and intramuscular infection. Notably, the heart blood PCR suggested that bovine PmA infection causes bacteremia (Supplementary Figure 1). Given the spleen has a blood filter function, it is unknown whether the bovine PmA was detained in the spleen or was subjected to colonization. Thus, this study regards the lung as the highest bacterial density tissue (28). Additionally, low bacteria density, if any, was detected in the lung intraperitoneally infected with E. coli DH5α, bovine mastitis E. coli, and S. typhimurium (Supplementary Figure 2), indicating that lung colonization is a feature of bovine PmA. Together, these data suggested that bovine PmA infection resulted in the lung having the highest bacterial density compared to other tissues.

It Is Found That AA and Asp Influence the Bovine PmA Growth via Comparing High- and Low-Bacterial Density Tissues Using Metabolomics

Many factors can influence bacterial density, including bacterial virulence factor, host immunity, nutrition, and so on (11, 13–15). To find some potential nutrition that shapes bovine PmA infection, we compared the metabolite profiles of the infected lung and liver using metabolomics. As shown in Figure 2A and Supplementary Figure 3, the metabolomics model is stable and credible and presents a sum of 99 differentially expressed metabolites, 70 in the infected lung and 29 in the infected liver. Next, a number of differentially expressed metabolites were screened whether they directly influence PmCQ2 growth in vitro. Although most of the differentially expressed metabolites had no effect on PmCQ2 growth, fortunately, it was found that AA and Asp inhibited and promoted PmCQ2 growth in a dose-dependent manner, respectively (Figures 2B,C and Supplementary Figure 4). Moreover, metabolomics data show that AA was expressed more in the infected liver while the Asp is expressed more in the infected lung, which is consistent with their effects on PmCQ2 (Supplementary Table 2). In addition, AA also inhibited PmCQ6 growth, indicating that the inhibitory effect is conservative among bovine PmA (Figure 2D). Together, these data indicated that both AA and Asp have direct functions on bovine PmA growth.

FIGURE 2

Figure 2. AA and Asp influenced bovine P. multocida growth in vitro. (A) The differently expressed metabolites of the mouse infected lung and liver. These mice were intranasally infected with 10⁴ log-phase PmCQ2 for 16 h and a total of eight mice were analyzed. (B) PmCQ2 impedance curves under different doses of AA or Asp supplementation. (C) PmCQ2 growth curves under different doses of AA or Asp supplementation. (D) PmCQ6 growth curves under different doses of AA. All experiments own three repeats for each group. *, **, ***, and **** represent P < 0.05, P < 0.01, P < 0.001, and P < 0.0001, respectively.

AA Inhibits PmCQ2 Virulence Factor Expression and Bovine PmA Infection Leads to AA Deficiency

Given bacterial virulence expression is important for colonization, whether AA and Asp could influence bovine PmA virulence gene expression was investigated. As shown in Figures 3A,B, Asp showed no impact on the virulence gene expression, whereas AA downregulated two virulence genes, OmpA and oma87, in a dose-dependent manner. Interestingly, in agreement with the metabolomics data, less AA was found in the infected lung than the liver with more OmpA expression (Figure 3C). In addition, it is found that AA significantly decreased PmCQ2 biofilm biogenesis while Asp promoted PmCQ2 biofilm biogenesis at low dosage (Figure 3D). It is well-known that biofilm is an important virulence factor for bacterial invasion to avoid host immunity system and drug (29). The above data implied that AA may restrain bovine PmA infection via inhibiting bacterial virulence expression. To identify whether bovine PmA would disrupt AA biogenesis, the expression of Gulo, a gene responsible for AA biogenesis in mice and cattle, was measured. As shown in Figure 3E, Gulo expression was inhibited by bovine PmA infection, indicating that AA biogenesis was damaged. In agreement with the Gulo expression result, AA deficiency was further evidenced by the downregulation of the AA concentrations in the infected lung (Figure 3F). Moreover, the level of AA in the infected lungs was significantly lower compared with the livers, which was consistent with the metabolomics data. Furthermore, the Asp metabolism pathway in the infected lungs were analyzed based on our former transcriptomic data. The RT-PCR results showed that the Asp metabolism pathway was enriched after PmCQ2 infection, indicating that Asp may play a role during PmCQ2 infection (Supplementary Figure 5). Together, these data indicated that AA inhibited PmCQ2 virulence factor expression and bovine PmA infection causes AA deficiency.

FIGURE 3

Figure 3. AA inhibited PmCQ2 virulence factor expression and its concentration was downregulated in the lung after PmCQ2 infection. (A) Analysis of some PmCQ2 virulence gene expression under different doses of L-aspartic acid. (B) Analysis of some PmCQ2 virulence gene expression under different doses of AA. Three repeats for each group. (C) The virulence gene, OmpA, expressions in the mice lung before infection or after 10⁴ CFU log-phase growth PmCQ2 infection for 16 h. Three repeats for each group. (D) PmCQ2 biofilm formation treated with different doses of AA or L-aspartic acid. Five repeats for each group. (E) The AA biogenesis gene Gulo expressions in the mice lung before infection or after receiving 10⁴ CFU log-phase growth PmCQ2 infection for 16 h. Three repeats for each group. (F) Comparison of AA concentrations in health mice lung and liver with mice intranasally infected with 10⁴ CFU log-phase growth PmCQ2 for 32 h. Six repeats for each group. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001, respectively.

Supplementation With AA Reduces Bacterial Loads and Increases Survival Rates of Mice

Afterwards, it is speculated that supplementation with exogenous AA can shape bovine PmA infection. Unsurprisingly, supplementation with AA reduces the bacterial burden of the infected lungs, demonstrating that exogenous AA acts as an anti-infection function (Figure 4A). On the contrary, supplementation of Asp is unable to change the bacterial density of the infected lung (Figure 4A). Moreover, although supplementation with Asp had no impact on mice mortality, supplementation with AA partially prevented infected mice from death, demonstrating that AA had a protective role during bovine PmA infection (Figures 4E,F). To further investigate the potential mechanism by which exogenous AA reduces bacterial density, we speculated that macrophage, which is responsible in clearing invaders via phagocytosis, might be involved in this process. First, various concentrations of AA and Asp were added to test the influence on the viability of macrophage. It is identified that the maximum concentration of AA without influencing macrophage viability is 100 μg/ml, which is consistent with a published paper (30), while Asp showed non-cytotoxicity in this work (Figure 4B). Next, as shown in Figures 4C,D, AA enhanced macrophage phagocytosis and decreased intracellular bacterial survival, while Asp is ineffective. Thus, the above data indicated that AA executed an anti-infection function in bovine PmA infection.

FIGURE 4

Figure 4. Supplementation of AA results in reduction bacteria density of the lung, promotion of macrophage bactericidal activity, and partial prevention of mice from death. (A) The bacteria density of the mouse lung infected with 10⁴ CFU log-phase growth PmCQ2 for 16 h. Mice were supplemented with AA, Asp, or saline for 7 days before infection. Every point indicates an individual. (B) Analysis of mouse peritoneal macrophage cell viability under different concentrations of AA or Asp. Five repeats for each group. (C) The phagocytosis of mouse peritoneal macrophage on PmCQ2. Cells were supplemented with 100 μg/ml AA, 5 mM Asp, or saline. Five repeats for each group. (D) The number of live PmCQ2 in mouse peritoneal macrophage. Five repeats for each group. (E) The survival rates of mice supplemented with different doses of AA or saline for 7 days. Mice were intraperitoneally infected with 10⁴ CFU log-phase growth PmCQ2. n represents how many mice were used in one experiment. (F) The survival rates of mice supplemented with different doses of Asp or saline for 7 days. Mice were intraperitoneally infected with 10⁴ CFU log-phase growth PmCQ2. n represents how many mice were used in one experiment. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001, respectively.

Discussion

Pasteurella multocida is a gram-negative pathogen and has various host types, including cattle, birds, pigs, cats, and dogs (31). Among them, bovine PmA is one of the most prevalent pathogen in cattle around the world, causing representative respiratory tract syndrome with high lethality (32, 33). In China, since 2008, the respiratory pathogen bovine PmA has replaced P. multocida serogroup B to become the most prevalent pathogen in clinics. Thus, preventing bovine PmA infection is of importance to most researchers. However, it is difficult for researchers to use cattle to investigate bovine P. multocida infection, because there are few available SFP cattle and the cost is also high for most researchers. To mimic P. multocida infection, most researchers selected mouse, and our previous work has demonstrated that the mouse model successfully mimics bovine P. multocida infection, showing similiar lung pathological changes with clinical samples (27, 34). In the present work, mice infected with PmCQ2, a bovine PmA strain, showed typical pneumonia symptoms, such as cough and abdominal respiration, and high lethality. Also, a serious inflammation reaction was further identified by H&E staining of the infected lungs (Figures 1A–C). Next, it is found that the lung had higher bovine PmA density than other tissues during infection, even though the bacterial density of the infected spleen had no significant difference with the infected lung in intraperitoneal and intramuscular injection groups (Figure 1D). In line with Collins' report, a bacteremia phenomenon was further identified in infected mice and cattle (our unpublished data), namely, spleen allows bacteria in the blood detained in the spleen via its blood filter function instead of colonization (Supplementary Figure 1) (11, 28). Thus, the lung was considered as the organ containing the highest bacterial density in this work.

An emerging problem has emerged: why does the lung have the highest bacterial density than others under bovine PmA infection? Generally, bacterial colonization is shaped by many factors, like virulence factor, host immunity, and nutrition. For example, Petrova and his co-workers reported that the virulence gene LGR1_llp1 of Lactobacillus rhamnosus influences its colonization in the vagina and the mutant strain shows half colonization number compared with the wild type (35). In addition, L-glutamine affects the expression of L. monocytogenes virulence genes and its colonization number in tissues (15). In our previous works, we have found that some amino acids, such as L-serine, L-arginine, L-proline, and L-glutamine, are closely related to bovine PmA infection (17–20). To find out potential nutrition shaping bovine PmA infection, we compared the metabolite profiles of high- and low-bacterial density tissues of the infected lung and liver using metabolomics. A total of 99 differently expressed metabolites were found, of which AA and Asp showed direct impact on bovine PmA growth in vitro (Figures 2A,B and Supplementary Figure 4). More specifically, AA inhibited bovine PmA growth, which expressed more in the infected liver than the lung, while the L-aspartic acid, which expressed more in the infected lung than the liver, showed promotion on bovine PmA growth (Figure 2C). Various papers have reported that AA, also called vitamin C, has an antimicrobial activity. For instance, AA has been reported to inhibit Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis growth (36). Mechanically, Vilchèze and his co-workers found that the AA operates its antimicrobial activity through disrupting bacterial Fenton reaction (37). In this study, it is found that the inhibitory effect of AA was conservative in bovine PmA as AA inhibits another bovine PmA PmCQ6 growth. Contrary to AA, few papers have reported that Asp promotes bacterial growth, and an example is that Asp enhances Acetobacter pasteurianus growth (38). Notably, a recent paper pointed out that the aspartate ammonia-lyase (aspA) in Pm is essential for bacterial growth in vitro (39).

Bacterial virulence gene expression is vital for bacterial colonization. In the present paper, it is found that AA regulates bovine PmA virulence factor expression. In order to verify whether AA and Asp directly regulated bovine PmA virulence gene expression, several virulence gene expressions were tested, including two identified in our lab, pm0442 (40) and pm0979 (unpublished data). As shown in Figures 3A,B, Asp has an irregular influence on the virulence gene expression, while AA repressed OmpA and oma87 expressions, and especially for OmpA, its inhibitory effect was in a dose-dependent manner (Figures 3A,B). Noteworthy, OmpA serves as a very important structural gene and virulence gene for P. multocida and is closely associated with outer membrane stability, bacterial adhesion, and colonization (41, 42). In addition, bacterial biofilm formation is a bacterial virulence factor through which bacteria escape from monitoring of the immune system and drug treatment (29), and a previous research indicated that OmpA was related to bacterial biofilm formation in P. multocida (26). Thus, it is speculated that the PmA biofilm formation can be reduced by AA. As shown in Figure 3D, bovine PmA biofilm formation is inhibited by AA, which is also consistent with published papers showing AA has a negative regulation on bacterial biofilm formation (43, 44). Consistent with previous results that infected lung owns less AA than the infected liver, higher OmpA expression was detected in the infected lung than the infected liver (Figure 3C). Unlike humans who rely on exogenous AA to meet physiological needs, mouse and cattle are capable to synthetize enough AA for themselves through a special gene Gulo, which only expresses in the liver (45, 46). Downregulation of Gulo expression is then found in the infected liver, indicating that AA biogenesis was damaged under bovine PmA infection (Figure 3E). Also, AA deficiency caused by the downregulation of Gulo was further evident by the reduction of the lung AA concentration after bovine PmA infection. One possible reason is that the supply of AA for peripheral organs, like the lung, was impaired, resulting in the compromised AA biogenesis. Additionally, the metabolomics data showing that AA expressed more in the infected liver than in the infected lung were examined by our AA kit (Figure 3F). So far, no published data has reported whether bovine PmA infection can influence AA concentrations in cattle, but an early paper indicated that the concentrations of AA were decreased in chiken cholera, which is caused by P. multocida infection (47).

The present work further speculated that supplementation with AA or Asp may have an impact on PmCQ2 infection. As shown in Figure 4A, supplementation with AA significantly reduced the lung bacterial density while supplementation with Asp only has an upward trend on lung bacterial density. Additionally, various papers have demonstrated that AA has an impact on macrophage function, and macrophages played a vital role during P. multocida infection (48). For instance, intracellular accumulation of pharmacologic AA concentrations in human monocytes inhibited its apoptosis pathway activation (49). In addition, other studies also found that supplementation with AA enhances phagocytosis and low intracellular AA restricts the ability of macrophage to clean the extracellular bacteria (50–52). Mechanically, phagocytosis mainly operated by macrophage and neutrophil produces much reactive oxygen species (ROS) to kill microbes, and excessive ROS can be neutralized by intracellular AA (53, 54). Accordingly, excessive accumulation of ROS reduces intracellular AA concentrations and impedes phagocytosis (55). Although Asp had no significant effect on changing bacterial density, it was set as a positive control for AA. First, it is found that 100 μg/ml AA was the maximum concentration for macrophage without interfering its viability, which is in line with previous reprorts (30, 56), while Asp seems to have no toxicity for macrophagy at 5 mM. Subsequently, phagocytosis and intracellular survival assays showed that phagocytosis and clearance of PmCQ2 were enhanced by AA, while Asp was ineffective (Figures 4C,D), implying that AA reduces the bacterial density via enhancing macrophage phagocytosis. However, further work needs to identify whether there are other mechanisms. Lastly, as shown in Figures 4E,F, supplementation with Asp had no effect on mice survival rate at least in our trials, but supplementation with AA significantly improved mice survival rate. However, the impact of AA supplementation on survival rate was in a dose-independent manner, and higher AA supplementation seems to have less benefit for survival rate. One possible cause is that AA damages cell viability and host coagulation function at an undesirably high concentration (57). A series of papers have demonstrated that supplementation with AA has an anti-infection effect. For example, AA supplementation effectively enhances animal resistance to endotoxin and tetanus toxin (58, 59). Furthermore, researches reported that supplementation of AA is beneficial for many bacterial diseases, like Helicobacter pylori infection, P. aeruginosa infection, Streptococcus pneumoniae infection, bacterial peritonitis, and bacterial sepsis (60–64). In the field of veterinary medicine, for instance, Hamdy's group found that AA supplementation can improve the survival rate of sheep in spontaneous pneumonia, and Naresh's group demonstrated that supplementation of AA can improve the recovery rate of dairy cows with mastitis in clinic (65, 66). Although mice and cattle synthesize enough AA under physiological conditions, AA deficiency resulting from reduction of Gulo expression was observed under bovine PmA infection in the present paper. In addition, in clinic, bovine PmA cases are constantly seen in calves or cattle that have been subjected to long-time or long-distance transportation. Notably, calves, unlike cattle, are unable to sythetize enough AA by themselves (67), showing AA deficiency. Likewise, Padilla's paper indicated that cattle suffers an AA deficiency under heat stress, and studies on other mammals, such as horse and goat, also demonstrated that transportation stress causes AA deficiency (68–70). Hence, it is assumed that cattle suffering from transportation stress might also show AA denficiency, which, in turn, make cattle sensitive to bovine PmA infection.

Although our mouse model successfully mimics bovine PmA infection, and based on our mouse model, the present work found that L-ascorbic acid shaped bovine PmA infection. The lack of direct evidence from cattle is a considerable limitation of this work. In addition, our primary work failed to find one optimal dose of L-ascorbic acid for supplementation and did not test or compare the effect of other supplementation methods, such as drinking and feeding. Thus, considering the clinical status and the limitations of the present work, our lab intends to start a systematic clinic trial to test the effect of AA supplementation on bovine PmA infection in our further works and, at the same time, to verify the mechanism on bovine cell lines mentioned in this work.

In conclusion, the current study found that AA shapes bovine PmA infection through comparing high- and low-bacterial density tissues. Mechanically, AA inhibited bovine PmA growth as well as virulence expression and regulated macrophage bactericidal activity. Moreover, bovine PmA infection caused AA deficiency and supplementation with AA reduced the bacterial density of the lung and improved mice survival rates, making AA a potential agent for the prevention of this disease in clinic.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.

Ethics Statement

The animal study was reviewed and approved by Ethics committee of Southwest University.

Author Contributions

YP, NL, and GZ have designed these experiments. GZ participated in all experiments and wrote this manuscript. PL and HM helped GZ do these experiments and analyze data. PL, NL, HM, and GZ revised this article. YP and NL approved the final manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work is supported by China Agriculture Research System of MOF and MARA (Beef/Yak Cattle, CARS-37), Chongqing Science & Technology Commission (cstc2017shms-zdyfx0036). The funding organizations had no role in study design, data collection or analysis, decision to publish or preparation.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The authors would like to thank Jixin Zhang, Teng Feng, and Zefeng Lin for the technical support and assistance.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fvets.2021.687922/full#supplementary-material

References

1. Wilson BA, Ho M. Pasteurella multocida: from zoonosis to cellular microbiology. Clin Microbiol Rev. (2013) 26:631–55. doi: 10.1128/CMR.00024-13

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Honnorat E, Seng P, Savini H, Pinelli PO, Simon F, Stein A. Prosthetic joint infection caused by Pasteurella multocida: a case series and review of literature. BMC Infect Dis. (2016) 16:435. doi: 10.1186/s12879-016-1763-0

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Carter GR. The type specific capsular antigen of Pasteurella multocida. Can J Med Sci. (1952) 30:48–53. doi: 10.1139/cjms52-008

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Kong LC, Gao D, Gao YH, Liu SM, Hongxia MA. Fluoroquinolone resistance mechanism of clinical isolates and selected mutants of Pasteurella multocida from bovine respiratory disease inchina. J Vet Med Sci. (2014) 76:1655–57. doi: 10.1292/jvms.14-0240

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Griffin D. Economic impact associated with respiratory disease in beef cattle. Vet Clin N Am Food Anim Pract. (1997) 13:367. doi: 10.1016/S0749-0720(15)30302-9

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Katsuda K, Hoshinoo K, Ueno Y, Kohmoto M, Mikami O. Virulence genes and antimicrobial susceptibility in Pasteurella multocida isolates from calves. Vet Microbiol. (2013) 167:737–41. doi: 10.1016/j.vetmic.2013.09.029

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Baggett HC, Watson NL, Deloria Knoll M, Brooks WA, Feikin DR, Hammitt LL, et al. Density of upper respiratory colonization with Streptococcus pneumoniae and its role in the diagnosis of pneumococcal pneumonia among children aged <5 years in the PERCH Study. Clin Infect Dis. (2017) 64:S317–27. doi: 10.1093/cid/cix100

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Edslev SM, Olesen CM, Nørreslet LB, Ingham AC, Iversen S, Lilje B, et al. Staphylococcal communities on skin are associated with atopic dermatitis and disease severity. Microorganisms. (2021) 9:432. doi: 10.3390/microorganisms9020432

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Blot M, Pauchard LA, Dunn I, Donze J, Malnuit S, Rebaud C, et al. Mechanical ventilation and Streptococcus pneumoniae pneumonia alter mitochondrial homeostasis. Sci Rep. (2018) 8:11718. doi: 10.1038/s41598-018-30226-x

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Dagleish MP, Finlayson J, Bayne C, MacDonald S, Sales J, Hodgson JC. Characterization and time course of pulmonary lesions in calves after intratracheal infection with Pasteurella multocida A:3. J Comp Pathol. (2010) 142:157–69. doi: 10.1016/j.jcpa.2009.10.015

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Collins FM, Niederbuhl CJ, Campbell SG. Bactericidal activity of alveolar and peritoneal macrophages exposed in vitro to three strains of Pasteurella multocida. Infect Immun. (1983) 39:779–84. doi: 10.1128/iai.39.2.779-784.1983

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Klemm P, Schembri MA. Bacterial adhesins: function and structure. Int J Med Microbiol. (2000) 290:27–35. doi: 10.1016/S1438-4221(00)80102-2

CrossRef Full Text | Google Scholar

13. Bosi P, Casini L, Finamore A, Cremokolini C, Merialdi G, Trevisi P, et al. Spray-dried plasma improves growth performance and reduces inflammatory status of weaned pigs challenged with enterotoxigenic Escherichia coli K88. J Anim Sci. (2004) 82:1764–72. doi: 10.2527/2004.8261764x

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Conway PL, Welin A, Cohen PS. Presence of K88-specific receptors in porcine ileal mucus is age dependent. Infect Immun. (1990) 58:3178–82. doi: 10.1128/iai.58.10.3178-3182.1990

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Haber A, Friedman S, Lobel L, Burg-Golani T, Sigal N, Rose J, et al. L-glutamine induces expression of listeria monocytogenes virulence genes. PLoS Pathog. (2017) 13:e1006161. doi: 10.1371/journal.ppat.1006161

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Luethy PM, Huynh S, Ribardo DA, Winter SE, Parker CT, Hendrixson DR. Microbiota-derived short-chain fatty acids modulate expression of Campylobacter jejuni determinants required for commensalism and virulence. mBio. (2017) 8:e00407-17. doi: 10.1128/mBio.00407-17

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Ren W, Liu S, Chen S, Zhang F, Li N, Yin J, et al. Dietary L-glutamine supplementation increases Pasteurella multocida burden and the expression of its major virulence factors in mice. Amino Acids. (2013) 45:947–55. doi: 10.1007/s00726-013-1551-8

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Ren W, Zou L, Li N, Wang Y, Liu G, Peng Y, et al. Dietary arginine supplementation enhances immune responses to inactivated Pasteurella multocida vaccination in mice. Br J Nutr. (2013) 109:867–72. doi: 10.1017/S0007114512002681

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Ren W, Zou L, Ruan Z, Li N, Wang Y, Peng Y, et al. Dietary L-proline supplementation confers immunostimulatory effects on inactivated Pasteurella multocida vaccine immunized mice. Amino Acids. (2013) 45:555–61. doi: 10.1007/s00726-013-1490-4

PubMed Abstract | CrossRef Full Text | Google Scholar

20. He F, Yin Z, Wu C, Xia Y, Wu M, Li P, et al. L-Serine lowers the inflammatory responses during Pasteurella multocida infection. Infect Immun. (2019) 87:e00677-19. doi: 10.1128/IAI.00677-19

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Chen S, Liu S, Zhang F, Ren W, Li N, Yin J, et al. Effects of dietary l -glutamine supplementation on specific and general defense responses in mice immunized with inactivated Pasteurella multocida vaccine. Amino Acids. (2014) 46:2365–75. doi: 10.1007/s00726-014-1789-9

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Wang H, Palmer J, Flint S. A rapid method for the nonselective enumeration of Yersinia enterocolitica, a foodborne pathogen associated with pork. Meat Sci. (2016) 113:59–61. doi: 10.1016/j.meatsci.2015.11.005

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Dey S, Bishayi B. Killing of S. aureus in murine peritoneal macrophages by ascorbic acid along with antibiotics chloramphenicol or ofloxacin: correlation with inflammation. Microb Pathog. (2018) 115:239–50. doi: 10.1016/j.micpath.2017.12.048

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Redlich S, Ribes S, Schutze S, Czesnik D, Nau R. Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 and Streptococcus pneumoniae R6 by microglial cells. J Neuroimmunol. (2012) 244:32–4. doi: 10.1016/j.jneuroim.2011.12.013

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Tang Y, Zhang X, Wu W, Lu Z, Fang W. Inactivation of the sodA gene of Streptococcus suis type 2 encoding superoxide dismutase leads to reduced virulence to mice. Vet Microbiol. (2012) 158:360–6. doi: 10.1016/j.vetmic.2012.02.028

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Kubera A, Thamchaipenet A, Shoham M. Biofilm inhibitors targeting the outer membrane protein A of Pasteurella multocida in swine. Biofouling. (2017) 33:14–23. doi: 10.1080/08927014.2016.1259415

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Wu C, Qin X, Li P, Pan T, Ren W, Li N, et al. Transcriptomic analysis on responses of murine lungs to Pasteurella multocida infection. Front Cell Infect Microbiol. (2017) 7:251. doi: 10.3389/fcimb.2017.00251

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. (2013) 39:806–18. doi: 10.1016/j.immuni.2013.10.010

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. (1999) 284:1318–22. doi: 10.1126/science.284.5418.1318

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Mahapatra SK, Chakraborty SP, Roy S. Immunomodulatory role of Ocimum gratissimum and ascorbic acid against nicotine-induced murine peritoneal macrophages in vitro. Oxid Med Cell Longev. (2011) 2011:734319. doi: 10.1155/2011/734319

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Wilkie IW, Harper M, Boyce JD, Adler B. Pasteurella multocida: diseases and pathogenesis. Curr Top Microbiol Immunol. (2012) 361:1–22. doi: 10.1007/82_2012_216

CrossRef Full Text | Google Scholar

32. Kong LC, Wang Z, Wang YM, Dong WL, Jia BY, Gao D, et al. Antimicrobial susceptibility and molecular typing of Pasteurella multocida isolated from six provinces in China. Trop Anim Health Prod. (2019) 51:987–92. doi: 10.1007/s11250-018-1754-9

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Dagleish MP, Bayne CW, Moon GG, Finlayson J, Sales J, Williams J, et al. Differences in virulence between bovine-derived clinical isolates of Pasteurella multocida serotype A from the UK and the USA in a model of bovine pneumonic pasteurellosis. J Comp Pathol. (2016) 155:62–71. doi: 10.1016/j.jcpa.2016.05.010

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Pors SE, Chadfield MS, Sorensen DB, Offenberg H, Bisgaard M, Jensen HE. The origin of Pasteurella multocida impacts pathology and inflammation when assessed in a mouse model. Res Vet Sci. (2016) 105:139–42. doi: 10.1016/j.rvsc.2016.02.007

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Petrova MI, Lievens E, Verhoeven TL, Macklaim JM, Gloor G, Schols D, et al. The lectin-like protein 1 in Lactobacillus rhamnosus GR-1 mediates tissue-specific adherence to vaginal epithelium and inhibits urogenital pathogens. Sci Rep. (2016) 6:37437. doi: 10.1038/srep37437

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Golonka I, Oleksy M, Junka A, Matera-Witkiewicz A, Bartoszewicz M, Musial W. Selected physicochemical and biological properties of ethyl ascorbic acid compared to ascorbic acid. Biol Pharm Bull. (2017) 40:1199–206. doi: 10.1248/bpb.b16-00967

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Vilcheze C, Hartman T, Weinrick B, Jacobs WR Jr. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nat Commun. (2013) 4:1881. doi: 10.1038/ncomms2898

PubMed Abstract | CrossRef Full Text

38. Yin H, Zhang R, Xia M, Bai X, Mou J, Zheng Y, et al. Effect of aspartic acid and glutamate on metabolism and acid stress resistance of Acetobacter pasteurianus. Microb Cell Fact. (2017) 16:109. doi: 10.1186/s12934-017-0717-6

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Wang Z, Li L, Liu P, Wang C, Lu Q, Liu L, et al. Role of aspartate ammonia-lyase in Pasteurella multocida. BMC Microbiol. (2020) 20:369. doi: 10.1186/s12866-020-02049-2

PubMed Abstract | CrossRef Full Text | Google Scholar

40. He F, Qin X, Xu N, Li P, Wu X, Duan L, et al. Pasteurella multocida Pm0442 affects virulence gene expression and targets TLR2 to induce inflammatory responses. Front Microbiol. (2020) 11:1972. doi: 10.3389/fmicb.2020.01972

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun. (2009) 77:3150–60. doi: 10.1128/IAI.00096-09

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Vougidou C, Sandalakis V, Psaroulaki A, Siarkou V, Petridou E, Ekateriniadou L. Distribution of the ompA-types among ruminant and swine pneumonic strains of Pasteurella multocida exhibiting various cap-locus and toxA patterns. Microbiol Res. (2015) 174:1–8. doi: 10.1016/j.micres.2015.02.003

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Pandit S, Ravikumar V, Abdel-Haleem AM, Derouiche A, Mokkapati V, Sihlbom C, et al. Low concentrations of vitamin C reduce the synthesis of extracellular polymers and destabilize bacterial biofilms. Front Microbiol. (2017) 8:2599. doi: 10.3389/fmicb.2017.02599

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Syal K, Bhardwaj N, Chatterji D. Vitamin C targets (p)ppGpp synthesis leading to stalling of long-term survival and biofilm formation in Mycobacterium smegmatis. FEMS Microbiol Lett. (2017) 364:fnw282. doi: 10.1093/femsle/fnw282

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Cha J, Roomi MW, Kalinovsky T, Niedzwiecki A, Rath M. Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice. Int J Oncol. (2016) 49:895–902. doi: 10.3892/ijo.2016.3597

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Consoli DC, Brady LJ, Bowman AB, Calipari ES, Harrison FE. Ascorbate deficiency decreases dopamine release in gulo(-/-) and APP/PSEN1 mice. J Neurochem. (2020) 157:656–65. doi: 10.1111/jnc.15151

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Squibb RL, Braham JE, Guzman M, Scrimshaw NSJPS. Blood serum total proteins, riboflavin, ascorbic acid, carotenoids and vitamin A of new hampshire chickens infected with coryza, cholera or newcastle disease. Poult Sci. (1955) 34:1054–8. doi: 10.3382/ps.0341054

CrossRef Full Text | Google Scholar

48. Li P, He F, Wu C, Zhao G, Hardwidge PR, Li N, et al. Transcriptomic analysis of chicken lungs infected with avian and bovine Pasteurella multocida serotype A. Front Vet Sci. (2020) 7:452. doi: 10.3389/fvets.2020.00452

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Perez-Cruz I, Carcamo JM, Golde DW. Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood. (2003) 102:336–43. doi: 10.1182/blood-2002-11-3559

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Shilotri PG. Glycolytic, hexose monophosphate shunt and bactericidal activities of leukocytes in ascorbic acid deficient guinea pigs. J Nutr. (1977) 107:1507–12. doi: 10.1093/jn/107.8.1507

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Carr AC, Maggini S. Vitamin C and immune function. Nutrients. (2017) 9:211. doi: 10.3390/nu9111211

CrossRef Full Text

52. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. (2006) 50:85–94. doi: 10.1159/000090495

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Bergsten P, Amitai G, Kehrl J, Dhariwal KR, Klein HG, Levine M. Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation. J Biol Chem. (1990) 265:2584–7. doi: 10.1016/S0021-9258(19)39841-2

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Qiao H, May JM. Macrophage differentiation increases expression of the ascorbate transporter (SVCT2). Free Radic Biol Med. (2009) 46:1221–32. doi: 10.1016/j.freeradbiomed.2009.02.004

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Wenisch C, Graninger W. Are soluble factors relevant for polymorphonuclear leukocyte dysregulation in septicemia? Clin Diagn Lab Immunol. (1995) 2:241–5. doi: 10.1128/cdli.2.2.241-245.1995

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Victor VM, Guayerbas N, Puerto M, De la Fuente M. Changes in the ascorbic acid levels of peritoneal lymphocytes and macrophages of mice with endotoxin-induced oxidative stress. Free Radic Res. (2001) 35:907–16. doi: 10.1080/10715760100301401

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Mohammed BM, Sanford KW, Fisher BJ, Martin EJ, Contaifer D Jr., et al. Impact of high dose vitamin C on platelet function. World J Crit Care Med. (2017) 6:37–47. doi: 10.5492/wjccm.v6.i1.37

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Dey PK. Efficacy of vitamin C in counteracting tetanus toxin toxicity. Naturwissenschaften. (1966) 53:310. doi: 10.1007/BF00712228

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Zhang XY, Xu ZP, Wang W, Cao JB, Fu Q, Zhao WX, et al. Vitamin C alleviates LPS-induced cognitive impairment in mice by suppressing neuroinflammation and oxidative stress. Int Immunopharmacol. (2018) 65:438–47. doi: 10.1016/j.intimp.2018.10.020

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Kastenbauer S, Koedel U, Becker BF, Pfister HW. Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy. Eur J Pharmacol. (2002) 449:177–81. doi: 10.1016/S0014-2999(02)01980-5

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Wang X, Willen R, Wadstrom T. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother. (2000) 44:2452–7. doi: 10.1128/AAC.44.9.2452-2457.2000

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Rawal BD, McKay G, Blackhall MI. Inhibition of Pseudomonas aeruginosa by ascorbic acid acting singly and in combination with antimicrobials: in-vitro and in-vivo studies. Med J Aust. (1974) 1:169–74. doi: 10.5694/j.1326-5377.1974.tb50784.x

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Wu F, Wilson JX, Tyml K. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol. (2003) 285:R50–6. doi: 10.1152/ajpregu.00564.2002

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Wu F, Wilson JX, Tyml K. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radic Biol Med. (2004) 37:1282–9. doi: 10.1016/j.freeradbiomed.2004.06.025

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Dwenger A, Pape HC, Bantel C, Schweitzer G, Krumm K, Grotz M, et al. Ascorbic acid reduces the endotoxin-induced lung injury in awake sheep. Eur J Clin Invest. (1994) 24:229–35. doi: 10.1111/j.1365-2362.1994.tb01079.x

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Naresh R, Dwivedi SK, Swarup D, Patra RC. Evaluation of ascorbic acid treatment in clinical and subclinical mastitis of indian dairy cows. Asian Aust J Anim Sci. (2002) 15:905–11. doi: 10.5713/ajas.2002.905

CrossRef Full Text | Google Scholar

67. Weiss WP. A 100-year review: from ascorbic acid to zinc-Mineral and vitamin nutrition of dairy cows. J Dairy Sci. (2017) 100:10045–60. doi: 10.3168/jds.2017-12935

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Minka NS, Ayo JO. Physiological and behavioral responses of goats to 12-hour road transportation, lairage and grazing periods, and the modulatory role of ascorbic acid. J Vet Behav Clin Appl Res. (2013) 8:349–56. doi: 10.1016/j.jveb.2013.01.001

CrossRef Full Text | Google Scholar

69. Ralston S, Stives M. Supplementation of ascorbic acid in weanling horses following prolonged transportation. Animals. (2012) 2:184–94. doi: 10.3390/ani2020184

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Matsui T. Vitamin C nutrition in cattle. Asian Aust J Anim Sci. (2012) 25:597–605. doi: 10.5713/ajas.2012.r.01

CrossRef Full Text | Google Scholar